Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma
Open Access
- 1 January 2017
- journal article
- case report
- Published by SAGE Publications in Journal of Pancreatic Cancer
- Vol. 3 (1) , 49-52
Abstract
Background: Gemcitabine, alone or in combination with other agents, has become an important part of the standard of care for treatment of both resectable and unresectable/advanced pancreatic adenocarcinoma. Gemcitabine is generally considered to have a favorable toxicity profile, with myelosuppression and hepatotoxicity as the most common adverse effects. There are just two prior published case reports of gemcitabine-associated digital toxicity in the treatment of pancreatic adenocarcinoma, and few case reports when considering all solid tumors. Presentation: A 70-year-old female developed hand numbness and tingling while receiving nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma. There was initial concern for Raynaud's or nab-paclitaxel-associated neuropathy, thus nab-paclitaxel was discontinued. However, her symptoms progressed to severe pain and her digits became dusky. An extensive evaluation revealed no alternative etiology except gemcitabine-associated digital ischemia (DI). The patient was treated with discontinuation of gemcitabine, and starting nitrates, opiates, calcium-channel blockers, and enoxaparin but eventually progressed to dry gangrene. Conclusion: Here we report a case of gemcitabine-associated DI, along with a review of the literature. Although a rare complication, DI must be recognized and treated promptly to reduce the likelihood of serious and permanent morbidity.Keywords
This publication has 11 references indexed in Scilit:
- Acute digital ischemia complicating gemcitabine and carboplatin combination chemotherapy for ovarian cancerActa Obstetricia et Gynecologica Scandinavica, 2011
- A Case of Progressive Digital Ischemia after Early Withdrawal of Gemcitabine and S-1 in a Patient with Systemic SclerosisJapanese Journal of Clinical Oncology, 2011
- Gemcitabine induced digital ischaemia and necrosisEuropean Journal of Cancer Care, 2010
- Digital ischemic events related to gemcitabine: Report of two cases and a systematic reviewRadiology and Oncology, 2010
- Gemcitabine: vascular toxicity and prothrombotic potentialExpert Opinion on Drug Safety, 2008
- Digital Ischemic Changes After Gemcitabine Therapy in a Patient with Metastatic Non–Small-Cell Lung CancerAnnals of Pharmacotherapy, 2007
- Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabineAnti-Cancer Drugs, 2003
- Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis.2003
- Purtscher Retinopathy and Necrotizing Vasculitis With Gemcitabine TherapyArchives of Ophthalmology (1950), 2000
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997